Page 113 - JCBP-3-1

Journal of Clinical and
Basic Psychosomatics Concerns about COVID-19 vaccination and AE rate

Writing – original draft: Isabel Hach Disease-specific adverse events following nonlive vaccines:
Writing – review & editing: All authors A paradoxical placebo effect or a nocebo phenomenon?
Vaccine. 2011;29(37):6321-6326.
Ethics approval and consent to participate doi: 10.1016/j.vaccine.2011.05.045

The institutional review board of the PMU Nuremberg has 9. Colloca L, Barsky AJ. Placebo and nocebo effects. N Engl J
evaluated the study approvingly (IRB 2022_003). The data Med. 2020;382(6):554-561.
protection officer of Klinikum Nuremberg confirmed that doi: 10.1056/NEJMra1907805
the study is general data protection regulation (GDPR)-
compliant. 10. Colloca L. The nocebo effect. Annu Rev Pharmacol Toxicol.
2024;64:171-190.
Consent for publication doi: 10.1146/annurev-pharmtox-022723-112425

Not applicable. 11. Haas JW, Bender FL, Ballou S, et al. Frequency of adverse
events in the placebo arms of COVID-19 vaccine trials:
Availability of data A systematic review and meta-analysis. JAMA Netw Open.
2022;5(1):e2143955.
After completion of the study and 6 months after
publication, we will make the raw data (excel file) available doi: 10.1001/jamanetworkopen.2021.43955. Erratum in:
in completely anonymized form after request (ca. 05/25). JAMA Netw Open. 2022;5(2):e221277.
doi: 10.1001/jamanetworkopen.2022.1277
References
12. Amanzio M, Mitsikostas DD, Giovannelli F, Bartoli M,
1. Holzmann-Littig C, Frank T, Schmaderer C, et al. Cipriani GE, Brown WA. Adverse events of active and
COVID-19 vaccines: Fear of side effects among German placebo groups in SARS-CoV-2 vaccine randomized trials:
health care workers. Vaccines (Basel). 2022;10(5):689. A systematic review. Lancet Reg Health Eur. 2022;12:100253.
doi: 10.3390/vaccines10050689 doi: 10.1016/j.lanepe.2021.100253
2. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy 13. Lee YH, Song GG. Nocebo responses in randomized
of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. controlled trials of COVID-19 vaccines. Int J Clin Pharmacol
2020;383(27):2603-2615. Ther. 2022;60(1):5-12.
doi: 10.1056/NEJMoa2034577 doi: 10.5414/CP204028
3. Yan Z, Yang M, Lai CL. COVID-19 vaccinations: A 14. Wartolowska K, Colloca L, Amanzio M. Editorial: The
comprehensive review of their safety and efficacy in special nocebo effect and its consequences for clinical trials and
populations. Vaccines (Basel). 2021;9(10):1097. clinical practice. Front Psychol. 2023;13:1111324.
doi: 10.3390/vaccines9101097 doi: 10.3389/fpsyg.2022.1111324
4. Mallah SI, Alawadhi A, Jawad J, et al. Safety and efficacy of 15. Bashar MA, Kamble B, Kumar S, Nandekar SV, Mathur SK.
COVID-19 prime-boost vaccinations: Homologous BBIBP- Assessment of safety and adverse events following
CorV versus heterologous BNT162b2 boosters in BBIBP- COVID-19 vaccination and their predictors in first 30 days
CorV-primed individuals. Vaccine. 2023;41(12):1925-1933. among healthcare workers of a tertiary care teaching hospital
in North India. Vaccine X. 2024;19:100522.
doi: 10.1016/j.vaccine.2023.01.032
doi: 10.1016/j.jvacx.2024.100522
5. Cai C, Peng Y, Shen E, et al. A comprehensive analysis of
the efficacy and safety of COVID-19 vaccines. Mol Ther. 16. Mitsikostas DD, Aravantinou-Fatorou K, Deligianni C,
2021;29(9):2794-2805. et al. Nocebo-prone behavior associated with SARS-CoV-2
vaccine hesitancy in healthcare workers. Vaccines (Basel).
doi: 10.1016/j.ymthe.2021.08.001
2021;9(10):1179.
6. Webster RK, Weinman J, Rubin GJ. A systematic review of
factors that contribute to nocebo effects. Health Psychol. doi: 10.3390/vaccines9101179
2016;35(12):1334-1355. 17. Mitsikostas DD, Deligianni CI. Q-No: A questionnaire
to predict nocebo in outpatients seeking neurological
doi: 10.1037/hea0000416
consultation. Neurol Sci. 2015;36(3):379-381.
7. Hutchinson P, Moerman DE. The meaning response, “placebo,” doi: 10.1007/s10072-014-1959-2
and methods. Perspect Biol Med. 2018;61(3):361-378.
18. Du Prel JB, Röhrig B, Hommel G, Blettner M. Choosing
doi: 10.1353/pbm.2018.0049
statistical tests: part 12 of a series on evaluation of scientific
8. Okaïs C, Gay C, Seon F, Buchaille L, Chary E, Soubeyrand B. publications. Dtsch Arztebl Int. 2010;107(19):343-348.

Volume 3 Issue 1 (2025) 107 doi: 10.36922/jcbp.4727